Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Who's the Boss? Merck Names Managerial Team As Schering-Plough Merger Looms

This article was originally published in The Pink Sheet Daily

Executive Summary

In hopes of convincing the world the deal is a reverse merger, Merck emphasizes the appointments of Schering-Plough execs to top jobs.

You may also be interested in...



Merck Names Ken Frazier President

The promotion moves Frazier one step closer to becoming CEO and Chairman when Dick Clark retires as expected next year.

Merck Names Ken Frazier President

The promotion moves Frazier one step closer to becoming CEO and Chairman when Dick Clark retires as expected next year.

Merck Vaccine President Slot Opens Up With McGlynn's Retirement

A consummate Merck insider, Margie McGlynn, announces her plans to retire, as the company prepares for its pending merger with Schering-Plough.

Related Content

Topics

UsernamePublicRestriction

Register

LL033172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel